Looking for some feedback from anyone in a similar situation.
I’m 34 with CLL and a NOTCH1 mutation. Because of NOTCH1’s association with increased Richter transformation risk, my CLL specialist has discussed starting Brukinsa (zanubrutinib) now rather than waiting until I meet traditional treatment criteria. His thought is that earlier treatment may help control the NOTCH1-positive clone/clonal evolution, but ultimately the decision is mine.
Has anyone else with NOTCH1 been given this option or chosen to treat early? I’d especially love to hear from anyone currently on Brukinsa—how you tolerate it, side effects, quality of life, etc.
My biggest hesitation is starting continuous treatment at 34 and potentially being on medication for many years. I’m trying to weigh that long-term exposure against the potential benefit of treating earlier, especially with the Richter concern.
I know everyone’s situation is different—just hoping to hear some real-life experiences from people who have faced a similar decision.